People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pardes Biosciences, Inc | — | Biotechnology | Series C | $51.6M | $1.7B | 2021 |
Elizabeth B. Lacy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elizabeth B. Lacy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James B. Tananbaum | 1 | 4 |
| Uri A. Loptain | 1 | 1 |
| Mark A. Aueurbach | 1 | 1 |
| Michael D. Varney | 1 | 1 |
| J. Jay B. Lobell | 1 | 1 |
| Heidi B. Henson | 1 | 1 |
| Lee B. Arnold | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.